221 results on '"Divgi, Chaitanya R."'
Search Results
2. A phase 1 study of JNJ-69086420 (JNJ-6420), an actinium-225 (225Ac) -labeled antibody targeting human kallikrein 2 (hK2), for metastatic castration-resistant prostate cancer (mCRPC).
3. Phase 2 Study of Iodine-131 Tositumomab Plus Chemotherapy in Patients With Previously Untreated Mantle-Cell Lymphoma
4. A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer
5. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO
6. Targeted Radionuclide Therapy for Bone Metastasis
7. Targeted Therapy for Bone Metastasis
8. The role of iodine-124 positron emission tomography in molecular imaging
9. A Review of Contemporary Data on Surgically Resected Renal Masses—Benign or Malignant?
10. Monoclonal Antibody Therapy of Kidney Cancer
11. Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors
12. Single Institution Experience with Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for the Primary Prevention of Lymphedema
13. Phase 1 study of JNJ-69086420, an actinium-225-labeled antibody targeting human kallikrein-2, for advanced prostate cancer.
14. Antibody Localization in Human Renal Cell Carcinoma: A Phase I Study of Monoclonal Antibody G250
15. Targeted Radionuclide Therapy for Bone Metastasis
16. Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer
17. Non-invasive assessment of tumor neovasculature: techniques and clinical applications
18. Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 ( 124I-cG250) and PET in patients with renal masses: a phase I trial
19. Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer
20. New strategies in radioimmunotherapy for lymphoma
21. Targeted Therapy for Bone Metastasis
22. In vitro and in vivo characterization of 177Lu-huA33 : A radioimmunoconjugate against colorectal cancer
23. Pretherapeutic first-in-human targeting trial of anti-hK2 antibody h11B6: A potential molecular vector for alpha-particle radioimmunotherapy.
24. Radiopharmaceutical Therapy of Cancer
25. Molecular Imaging of Pulmonary Cancer and Inflammation
26. Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma
27. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas
28. Radiolabelled Monoclonal Antibody Imaging in Cancer: Potential and Limitations
29. Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients
30. Monoclonal antibody-based therapy for renal cell carcinoma
31. Phase 0 study to assess [111In]-DOTA-h11B6 to target human kallikrein-2 (hk2) in men with metastatic castration-resistant prostate cancer.
32. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO
33. Targeted α particle immunotherapy for myeloid leukemia
34. Single chain antigen binding protein (sFv CC49): first human studies in colorectal carcinoma metastatic to liver
35. Localization of Complement-Fixing Cytotoxic Monoclonal Antibodies to Subcutaneous Tumors and Liver Metastases in a Syngeneic Immunocompetent Rat Colon Carcinoma Model
36. Murine and humanized constructs of monoclonal antibody M195 (Anti-CD33) for the therapy of acute myelogenous leukemia
37. Overview of clinical radioimmunodetection of human tumors
38. Tumor Burden Assessment with Positron Emission Tomography with [18-F] 2-fluoro 2-deoxyglucose (FDG PET) Modeled in Metastatic Renal Cell Cancer
39. Imaging Characterization of Thyroid Nodules
40. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas
41. Whole-Body Low-Dose Computed Tomography and Advanced Imaging Techniques for Multiple Myeloma Bone Disease
42. American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2014) e-Century Publishing Corporation
43. American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2012) e-Century Publishing Corporation
44. Longer Duration of Red Blood Cell Storage Induces Progressively Increased Markers of Extravascular Hemolysis and Hepcidin in Autologously Transfused Healthy Volunteers
45. Monoclonal Antibodies in Advanced Renal Cell Carcinoma
46. Radioimmunotherapy: Current Status and Future Directions
47. Whole-Body Low-Dose Computed Tomography and Advanced Imaging Techniques for Multiple Myeloma Bone Disease
48. Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model
49. Development of 124I Immuno-PET Targeting Tumor Vascular TEM1/Endosialin
50. Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.